Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, KMS Medisurgi's Enterprise Value is ₹434.9 Mil.
KMS Medisurgi's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.4 Mil. Therefore, KMS Medisurgi's EV-to-EBIT ratio for today is 99.57.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, KMS Medisurgi's Enterprise Value is ₹434.9 Mil.
KMS Medisurgi's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹9.1 Mil. Therefore, KMS Medisurgi's EV-to-EBITDA ratio for today is 47.89.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, KMS Medisurgi's Enterprise Value is ₹434.9 Mil.
KMS Medisurgi's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹122.1 Mil. Therefore, KMS Medisurgi's EV-to-Revenue ratio for today is 3.56.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, KMS Medisurgi's Enterprise Value is ₹434.9 Mil.
KMS Medisurgi's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.2 Mil. Therefore, KMS Medisurgi's EV-to-FCF ratio for today is 2,528.65.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
KMS Medisurgi (BOM:540468) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
KMS Medisurgi's current Enterprise Value is ₹434.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. KMS Medisurgi's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.4 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
KMS Medisurgi's current Enterprise Value is ₹434.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. KMS Medisurgi's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹9.1 Mil.
KMS Medisurgi's current Enterprise Value is ₹434.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. KMS Medisurgi's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹122.1 Mil.
KMS Medisurgi's current Enterprise Value is ₹434.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. KMS Medisurgi's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was ₹15.1 Mil.
KMS Medisurgi's current Enterprise Value is ₹434.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. KMS Medisurgi's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KMS Medisurgi Enterprise Value Related Terms
KMS Medisurgi Enterprise Value Historical Data
* Premium members only.
The historical data trend for KMS Medisurgi's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:540468 vs ISRG, BDX, MDLN: Enterprise Value Comparison
For the Medical Instruments & Supplies subindustry, KMS Medisurgi's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMS Medisurgi Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KMS Medisurgi's Enterprise Value distribution charts can be found below:
* The bar in red indicates where KMS Medisurgi's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
KMS Medisurgi's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KMS Medisurgi (BOM:540468) has a Enterprise Value of ₹434.9 Mil as of Jul. 16, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on KMS Medisurgi and its competitors.
Is KMS Medisurgi's Enterprise Value too high?
KMS Medisurgi's current Enterprise Value is ₹434.9 Mil. Overall, KMS Medisurgi has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KMS Medisurgi's Enterprise Value compare to ISRG and BDX?
KMS Medisurgi's Enterprise Value of ₹434.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on KMS Medisurgi and its competitors. KMS Medisurgi's current Enterprise Value is ₹434.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMS Medisurgi stock overvalued right now?
Based on GuruFocus' analysis, KMS Medisurgi (BOM:540468) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹111.50, compared to a current price of ₹132.80 — trading 19.1% above its estimated fair value. The current Enterprise Value is ₹434.9 Mil. KMS Medisurgi's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For KMS Medisurgi (BOM:540468), the current Enterprise Value is ₹434.9 Mil as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMS Medisurgi (BOM:540468) Overvalued in 2026?
Based on GuruFocus' analysis, KMS Medisurgi stock appears to be overvalued.
The current stock price of ₹132.80 is trading 19.1% above its estimated GF Value™ of ₹111.50.
GuruFocus considers KMS Medisurgi to be Modestly Overvalued.
Key valuation signals for BOM:540468:
Enterprise Value: ₹434.9 Mil
GF Value™: ₹111.50 vs. price of ₹132.80 (19.1% above fair value)
No single metric tells the full story. See the BOM:540468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMS Medisurgi Ltd manufactures surgical tapes and dressings for hospitals, institutions, trade associations, exporters, and importers. The company manufactures and undertakes job work of various substartes like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. The company's international presence includes Vietnam, Dubai, Europe, Australia, Cambodia, India, Africa, Philippines, Russia, Pakistan, Bangladesh, and the USA. The company derives revenue from the sale of goods.
79GF Score
Get the complete analysis for BOM:540468
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540468 has been successfully added to your 
